Book contents
- Cambridge Handbook of Pain Medicine
- Cambridge Handbook of Pain Medicine
- Copyright page
- Contents
- Contributors
- Pain Handbook Introduction
- Part I Introduction to Pain: Pain Signaling Pathways
- Part II Common Categories of Pharmacologic Medications to Treat Chronic Pain
- Part III Chronic Pain Conditions Head and Neck
- Part IV Spine
- Part V Extremities
- Part VI Misc
- Chapter 26 Post-herpetic Neuralgia (PHN)
- Chapter 27 Complex Regional Pain Syndrome (CRPS)
- Chapter 28 Sickle Cell Disease
- Chapter 29 Breast Pain
- Chapter 30 Post-thoracotomy Pain
- Chapter 31 Multiple Sclerosis Pain
- Chapter 32 Cerebral Palsy
- Chapter 33 Myofascial Pain Syndrome
- Chapter 34 Post-stroke Pain
- Chapter 35 Chronic Abdominal Pain
- Chapter 36 Chronic Pelvic Pain
- Chapter 37 Postsurgical Nerve Entrapment
- Chapter 38 Cancer Pain
- Part VII Adjunctive Therapy
- Index
- References
Chapter 32 - Cerebral Palsy
from Part VI - Misc
Published online by Cambridge University Press: 01 December 2023
Book contents
- Cambridge Handbook of Pain Medicine
- Cambridge Handbook of Pain Medicine
- Copyright page
- Contents
- Contributors
- Pain Handbook Introduction
- Part I Introduction to Pain: Pain Signaling Pathways
- Part II Common Categories of Pharmacologic Medications to Treat Chronic Pain
- Part III Chronic Pain Conditions Head and Neck
- Part IV Spine
- Part V Extremities
- Part VI Misc
- Chapter 26 Post-herpetic Neuralgia (PHN)
- Chapter 27 Complex Regional Pain Syndrome (CRPS)
- Chapter 28 Sickle Cell Disease
- Chapter 29 Breast Pain
- Chapter 30 Post-thoracotomy Pain
- Chapter 31 Multiple Sclerosis Pain
- Chapter 32 Cerebral Palsy
- Chapter 33 Myofascial Pain Syndrome
- Chapter 34 Post-stroke Pain
- Chapter 35 Chronic Abdominal Pain
- Chapter 36 Chronic Pelvic Pain
- Chapter 37 Postsurgical Nerve Entrapment
- Chapter 38 Cancer Pain
- Part VII Adjunctive Therapy
- Index
- References
Summary
Cerebral palsy (CP) is a neurological disorder that greatly affects movement and occurrence of muscle spasticity as well as other problems. Cerebral palsy significantly decreases quality of life in patients.Causes of CP are still not fully known but prenatal complications as well as trauma during pregnancy can lead to higher risk. It is recommended for expecting mothers to not overexert themselves during pregnancy and keep consistent health checkups to prevent causative factors. Current treatments to reduce spasticity and other symptoms involve botulinum toxin type A, intrathecal baclofen, dorsal rhizotomy, dantrolene, diazepam, flexeril, and tizanidine. Each method prevents some level of relief, but all come with their own existing risks and adverse effects. Patients must outweigh the risk over potential gain with the use of each treatment for pain and spasticity.
- Type
- Chapter
- Information
- Cambridge Handbook of Pain Medicine , pp. 253 - 260Publisher: Cambridge University PressPrint publication year: 2023
References
Krigger, KW. Cerebral palsy: An overview. Am Fam Physician. 2006;73(1):91–100. www.aafp.org/pubs/afp/issues/2006/0101/p91.html.Google ScholarPubMed
Bonellie, S, Currie, D, Chalmers, J. Comparison of risk factors for cerebral palsy in twins and singletons. Dev Med Child Neurol. 2022;47(9):587–591. https://doi.org/10.1111/J.1469-8749.2005.TB01208.X.CrossRefGoogle Scholar
Graham, HK, Rosenbaum, P, Paneth, N et al. Cerebral palsy. Nat Rev Dis Primers. 2016;2(1):1–25. https://doi.org/10.1038/nrdp.2015.82.Google ScholarPubMed
Guillamón, N, Nieto, R, Pousada, M et al. Quality of life and mental health among parents of children with cerebral palsy: The influence of self-efficacy and coping strategies. J Clin Nurs. 2013;22(11–12):1579–1590. https://doi.org/10.1111/JOCN.12124.CrossRefGoogle ScholarPubMed
Wimalasundera, N, Stevenson, VL. Cerebral palsy. Pract Neurol. 2016;16(3):184–194. https://doi.org/10.1136/PRACTNEUROL-2015-001184.CrossRefGoogle ScholarPubMed
Byrne, R, Noritz, G, Maitre, NL. Implementation of early diagnosis and intervention guidelines for cerebral palsy in a high-risk infant follow-up clinic. Pediatr Neurol. 2017;76:66–71. https://doi.org/10.1016/J.PEDIATRNEUROL.2017.08.002.CrossRefGoogle Scholar
Vitrikas, K, Dalton, H, Breish, D. Cerebral palsy: An overview. Am Fam Physician. 2020;101(4):213–220. https://doi.org/10.4274/hamidiyemedj.galenos.2021.72792.Google ScholarPubMed
Himmelmann, K, Ahlin, K, Jacobsson, B, Cans, C, Thorsen, P. Risk factors for cerebral palsy in children born at term. Acta Obstet Gynecol Scand. 2011;90(10):1070–1081 https://doi.org/10.1111/j.1600-0412.2011.01217.x.CrossRefGoogle ScholarPubMed
Bax, M, Tydeman, C, Flodmark, O. Clinical and MRI correlates of cerebral palsy: The European cerebral palsy study. JAMA. 2006;296(13):1602–1608. https://doi.org/10.1001/JAMA.296.13.1602.CrossRefGoogle ScholarPubMed
Pass, RF, Fowler, KB, Boppana, SB, Britt, WJ, Stagno, S. Congenital cytomegalovirus infection following first trimester maternal infection: Symptoms at birth and outcome. J Clin Virol. 2006;35(2):216–220. https://doi.org/10.1016/J.JCV.2005.09.015.CrossRefGoogle ScholarPubMed
Neufeld, MD, Frigon, C, Graham, AS, Mueller, BA. Maternal infection and risk of cerebral palsy in term and preterm infants. J Perinatol. 2005;25(2):108–113. https://doi.org/10.1038/SJ.JP.7211219.CrossRefGoogle ScholarPubMed
Wu, YW, Escobar, GJ, Grether, JK et al. Chorioamnionitis and cerebral palsy in term and near-term infants. JAMA. 2003;290(20):2677–2684. https://doi.org/10.1001/JAMA.290.20.2677.CrossRefGoogle ScholarPubMed
Gibson, CS, MacLennan, AH, Goldwater, PN et al. Neurotropic viruses and cerebral palsy: Population based case-control study. BMJ. 2006;332(7533):76–79. https://doi.org/10.1136/BMJ.38668.616806.3A.CrossRefGoogle ScholarPubMed
Pharoah, POD. Cerebral palsy in the surviving twin associated with infant death of the co-twin. Arch Dis Child Fetal Neonatal Ed. 2001;84(2):F111–F116. https://doi.org/10.1136/FN.84.2.F111.CrossRefGoogle ScholarPubMed
Scher, AI, Petterson, B, Blair, E et al. The risk of mortality or cerebral palsy in twins: A collaborative population-based study. Pediatr Res. 2002;52(5):671–681. https://doi.org/10.1203/00006450-200211000-00011.CrossRefGoogle ScholarPubMed
Glinianaia, SV, Jarvis, S, Topp, M et al. Intrauterine growth and cerebral palsy in twins: A European multicenter study. Twin Res Hum Genet. 2006;9(3):460–466. https://doi.org/10.1375/183242706777591209.CrossRefGoogle ScholarPubMed
Jarvis, S, Glinianaia, SV, Torrioli, MG et al. Cerebral palsy and intrauterine growth in single births: European collaborative study. Lancet. 2003;362(9390):1106–1111. https://doi.org/10.1016/S0140-6736(03)14466-2.CrossRefGoogle ScholarPubMed
Reddihough, DS, Collins, KJ. The epidemiology and causes of cerebral palsy. Aust J Physiother. 2003;49(1):7–12. https://doi.org/10.1016/S0004-9514(14)60183-5.CrossRefGoogle ScholarPubMed
Upadhyay, J, Tiwari, N, Ansari, MN. Cerebral palsy: Aetiology, pathophysiology and therapeutic interventions. Clin Exp Pharmacol Physiol. 2020;47(12):1891–1901. https://doi.org/10.1111/1440-1681.13379.CrossRefGoogle ScholarPubMed
Hankins, GDV, Speer, M. Defining the pathogenesis and pathophysiology of neonatal encephalopathy and cerebral palsy. Obstet Gynaecol. 2003;102(3):628–636. https://doi.org/10.1016/S0029-7844(03)00574-X.Google ScholarPubMed
Jacquelin Peck, B, Urits, I, Kassem, H et al. Interventional approaches to pain and spasticity related to cerebral palsy. Psychopharmacol Bull. 2020;50(4 Suppl 1):108–120.Google Scholar
Delgado, MR, Hirtz, FD, Aisen, FM et al. Practice parameter: Pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review). Neurology. 2010;74(4):336–343.CrossRefGoogle ScholarPubMed
Jacki Peck, B, Urits, I, Crane, J et al. Oral muscle relaxants for the treatment of chronic pain associated with cerebral palsy. Psychopharmacol Bull. 2020;50(4 Suppl 1):142–162.Google Scholar
Sinatra, R, Jahr, J, Watkins-Pitchford, J (Eds.). In The essence of analgesia and analgesics. Cambridge: Cambridge University Press. Published online January 1, 2022. pp. 375–378. https://doi.org/10.1017/CBO9780511841378.094.Google Scholar